GRTX Galera Therapeutics, Inc.
16.28USD0.00%Mkt Cap: 3.38B $P/E: 0.1480d ago
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.38B USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price16.28 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.14
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
3.00049% of range30.00
52W High30.00 USD
52W Low3.000 USD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate—
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg—
Avg Vol (30d)365
Avg Vol (10d)—
Technical Indicators
RSI (14)42.1
MACD-0.4760
MACD Signal-0.3116
MACD Hist.-0.1644
BB Upper19.44 USD
BB Middle17.39 USD
BB Lower15.33 USD
BB Width23.63%
ATR (14)1.053 USD
Vol Ratio (20d)0.00x